DiaMedica Therapeutics (DMAC) Share-based Compensation (2018 - 2026)
DiaMedica Therapeutics (DMAC) posted Share-based Compensation of $1.12 million for Q2 2026, up 45.0% from $771,000 a year earlier and up 36.0% from the prior quarter.
Powered by 
Analysis
DiaMedica Therapeutics (DMAC) Share-based Compensation (2018 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Share-based Compensation at DiaMedica Therapeutics was $4.15 million, up 48.6% year-over-year; for FY2025, it came in at $3.85 million, up 84.5% from FY2024.
- Annual Share-based Compensation has increased for three consecutive years, with a five-year compound annual growth rate of 15.9% (FY2020 to FY2025).
- In prior years, DiaMedica Therapeutics' Share-based Compensation was $2.09 million in FY2024 (+23.9%), $1.68 million in FY2023 (+12.1%), $1.5 million in FY2022 (-3.6%) and $1.56 million in FY2021 (-15.5%).
- Quarterly Share-based Compensation has run from a low of $298,000 in Q4 2021 to a high of $1.19 million in Q4 2025 over five years.
- On a year-over-year basis, Share-based Compensation increased in seven of the last eight quarters, with growth averaging 54.5%.
- The strongest year-over-year quarter for Share-based Compensation in the past five years was Q4 2025, with growth of 102.4%; the weakest was Q4 2021, with a decline of 41.1%.
- According to Business Quant data, Share-based Compensation for the three prior quarters was $822,000 (Q1 2026), $1.19 million (Q4 2025) and $1.02 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,164.36 Bn | 1,132.95 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 634.54 Bn | 553.07 Bn | 17.26 Bn | 458.00 Mn |
| 3 | AbbVie | 502.85 Bn | 475.96 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 376.50 Bn | 330.88 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 303.65 Bn | 267.64 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 266.62 Bn | 240.30 Bn | 12.86 Bn | - |
| 7 | Amgen | 241.17 Bn | 196.57 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 193.39 Bn | 167.59 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 172.45 Bn | 119.10 Bn | 10.94 Bn | 249.00 Mn |
| 10 | DiaMedica Therapeutics | 482.16 Mn | 272.12 Mn | - | 1.12 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.12 Mn |
| Mar 31, 2026 | 822,000.00 |
| Dec 31, 2025 | 1.19 Mn |
| Sep 30, 2025 | 1.02 Mn |
| Jun 30, 2025 | 771,000.00 |
| Mar 31, 2025 | 867,000.00 |
| Dec 31, 2024 | 589,000.00 |
| Sep 30, 2024 | 565,000.00 |
| Jun 30, 2024 | 443,000.00 |
| Mar 31, 2024 | 488,000.00 |
| Dec 31, 2023 | 456,000.00 |
| Sep 30, 2023 | 425,000.00 |
| Jun 30, 2023 | 380,000.00 |
| Mar 31, 2023 | 422,000.00 |
| Dec 31, 2022 | 411,000.00 |
| Sep 30, 2022 | 418,000.00 |
| Jun 30, 2022 | 365,000.00 |
| Mar 31, 2022 | 308,000.00 |
| Dec 31, 2021 | 298,000.00 |
| Sep 30, 2021 | 303,000.00 |
API Access
DiaMedica Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=DMAC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "DMAC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=DMAC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();